Bin Wang is a team-oriented medicinal and synthetic chemist with a PhD in Organic Chemistry from Colorado State University. They served as a Postdoctoral Fellow at Boston College from 2008 to 2010, where they completed the total synthesis of Sclerophytin A under the guidance of Prof. James Morken. From 2010 to 2023, Bin worked at Enanta Pharmaceuticals as a Principal Scientist, focusing on small molecules R&D for Nonalcoholic Steatohepatitis and developing inhibitors for Hepatitis C Virus. Bin currently holds the position of Principal Investigator at Biohaven, continuing their dedication to research and innovation in the field.
Location
Watertown, United States
This person is not in the org chart
This person is not in any offices